What did @megloulife actually say?
Honestly, the transcript here is not usable. The audio captured appears to be lyrics from Don McLean's "American Pie" rather than anything @megloulife actually said about her weight loss journey. The caption, though, tells a specific story: 108 lbs lost over 16 months, dropping from a 4XL to a medium. That is the claim we can actually work with, and it is a significant one worth examining carefully.
The video has 340,200 views, which means a lot of people are seeing this result and potentially using it as a benchmark for their own expectations. That is reason enough to look hard at whether 108 lbs in 16 months is plausible, exceptional, or something else entirely on GLP-1 therapy.
Does the science back this up?
The short answer is yes, it is biologically possible, but it sits well above average trial results. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found tirzepatide produced mean weight loss of up to 22.5% of body weight over 72 weeks at the highest dose. For someone starting at roughly 270-280 lbs, which is a reasonable estimate given the size description, 108 lbs would represent roughly 38-40% total body weight loss.
That exceeds what most clinical trials report as average. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4 mg produced about 14.9% mean weight loss over 68 weeks. Individual results vary enormously based on adherence, diet, activity, baseline metabolic health, and which GLP-1 medication was used. High responders exist. But "high responder" is not the same as "typical."
What did they get wrong, or right?
There is nothing factually wrong in the caption claim itself. Losing 108 lbs over 16 months is within the realm of documented human physiology, especially with GLP-1 support combined with behavioral changes. Clothing size shift from 4XL to medium is consistent with that magnitude of loss.
What is missing is context. There is no mention of which GLP-1 medication, what dose, what dietary changes accompanied it, whether there was exercise, or what the starting weight actually was. Without those variables, this result functions as a highlight reel, not a roadmap. Research consistently shows that GLP-1 medications work best alongside caloric reduction and increased physical activity (Davies et al., 2021, Lancet). Framing the result without that context can create unrealistic expectations for viewers who may be starting their own GLP-1 journey at a different baseline.
What should you actually know?
GLP-1 receptor agonists are legitimate, well-studied tools for weight management. The evidence base is real. But the range of outcomes is wide, and social media naturally amplifies exceptional results because they get the most views.
- Average weight loss in major trials ranges from 10% to 22% of starting body weight depending on the drug and dose.
- Results plateau for most people, and weight regain after stopping medication is well-documented (Wilding et al., 2022, Diabetes, Obesity and Metabolism).
- Clothing size changes are not a clinical metric. Body composition, metabolic markers, and cardiovascular risk factors are more meaningful endpoints.
- If you are on a GLP-1 and not seeing results like this after several months, that does not mean the medication is failing you. It may mean you are a typical responder rather than an outlier.
The caption result is inspirational, and inspiration has value. Just do not let one person's exceptional outcome become your personal minimum acceptable result.